Clinical Trials Directory

Trials / Completed

CompletedNCT05380362

Prospective Randomized Endovascular Therapy in Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University at Buffalo · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

1. To assess the safety of endovascular therapy (balloon angioplasty) for venous stenoses in MS patients with CCSVI as documented by sonographic (extracranial echocolor-Doppler (ECD) and transcranial color Doppler (TCD) 2. To study the morphology of the venous anomalies by using intraluminal ultrasound (IVUS). 3. To evaluate preliminary efficacy of endovascular therapy (angioplasty) as measured by clinical (relapse rate, disability progression (EDSS)), sonographic (ECD/TCD) and MRI/MRV parameters. 4. To evaluate change in patients self-reported QOL following the therapeutic angioplasty 5. To evaluate whether changes in QOL, fatigue, MSFC or attention following therapeutic angioplasty are associated with brain changes as measured by functional MRI (fMRI).

Conditions

Interventions

TypeNameDescription
OTHERVenous Angioplastyvenous angiogram to look for lesions or flaps and then plastying vessels open.
OTHERSham AngioplastyPatients will be brought to the angio suite and will not know if they are having the venous angioplasty or not.

Timeline

Start date
2010-06-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2022-05-18
Last updated
2025-08-22
Results posted
2025-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05380362. Inclusion in this directory is not an endorsement.